Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are you also as excited about vk5211?
Yes, setting the stage for VK2809 which IMO is a better drug than MDGL's. VK2809 is going to be a huge Blockbuster Billion dollar drug.
So, I think mdgl p2 readout in Q4 going to be an important readout for vktx as well
That’s the question and that’s why we are bullish.
Maxim is not credible .. Zack is good in more cases .. $7 is price target now , so assumes some % of failure for VK5211 .. am guessing 70% success probability
So Zack assumes $10 if success and $2 if it failes !!!
Zacks has a 7.00 target, Maxim Group 5.00
What are price targets or market cap targets if
A) VK5211 meets primary in 2 weeks
B) It does not meet
Yes! This seems to be an afternoon runner.
A breakout above 2.00 could happen at any moment, ....looking forward to it.
GLTA
You mite need to do some digging. Not sure if retail investors know the answer to the question you have always had.
Exactly. Ligand stands to gain a lot of Viking succeeds. 40% ownership is no joke. Having said that, I do wish they had gone with someone other than Lincoln Park. These guys don't have a good reputation.
This arrangement is consistent with the Ligand business model plus Ligand owns about 40% of VKTX.
My question has always been if this drug was such a cert, why did ligand hand it over and ask for only a 6% cut of the revenue.
Given the recent movement in price, I am feeling optimistic. Almost feels as if someone "knows" something. Also, this drug was originally part of Ligand and they are a multi billion $ Bio Tech, as well as a large shareholder in VKTX.
Imo, I feel we have a strong chance in passing. I understand our stock price has risen the last few weeks but fundamentally I feel our market cap is quite low to others in the space. We have lots of room for growth.
What's the chance of the test passing?
I'm not sure what measure they're using to show a statistically significant change in muscle mass:-
https://clinicaltrials.gov/ct2/show/NCT02578095
Presumably the risk is that the drug doesn't work in older and sedentary adults unlink the young body builder types who have been taking this drug online.
It is indeed. I'm not sure if it is going to be a rehash of data already presented or something materially new. Conferences usually require that presenters share new data. Not sure what the policy is with this conference. Anyway I think this conference will just be a bonus for October. Hip data at the KOL (most likely) will be the key value driver.
$VKTX has 13 Mil. in the bank and another 15 mil. available.
a Well funded company.
https://www.sec.gov/Archives/edgar/data/1607678/000095012317008702/vktx-424b5.htm#S11_UseProceeds
Thanks for the link. Very exciting. Especially bc both our drugs fit within the endocrine space, looking forward to the conference
Well then, It looks as if we will see some data on VK2809 Oct 20 - 24.
Thanks for posting that. October is going to be a great month for VKTX.
enjoy the ride
That's what I thought as well. By the way, I'm curious if we will get any new info at AASLD on Oct 20-24.
VK5211 on deck 10/9 , I'm not sure if we get other readouts by EOY. But in Q1 Phase 2 vk2809 results coming in strong IMO.
Besides musculoskeletal data, do we anticipate any other readouts in Q4? I suppose NASH update won't be coming until H1'18.
wow 2.00 AH ...it traded all over the place today...but in the end longs/ Buyers ruled the day!!!! next week will be Epic ...
I have a 2.50 price target by Friday leading up to 10/9 Presentation with possible Phase 2 results.
5.00 target for October.
VKTX
What a Epic week it was, congrats to the longs here. Yes Patience was needed during this summer's Lull. I was starting to losing my mind if you happened to read some of my Rants during summer ....but it was all worth it.
and my Perspective....going to 5.00 by End of the year.
VKTX
$2 and close to 10k volume after hours. Next week should be fun and hopefully data on the 9th.
Have a great weekend all!
No joke!
Looking good
Patience And
Perspective
$VKTX
good to see you here,Stick around, the Party is just getting started.
VKTX
Haven't gone anywhere
Much love brother
miss ya brother!!
The way its moving up tells me we will get vk5211 Phase 2 results on 10/9
GLTA
Love it. Let’s make some money boys.
What a day! Will be fun going into data next month. And of course, the right results could make it even better. GL to you and all on board!
VKTX on fire.... chart looks A+ perfect for a roll up to 2.50 before 10/9 .
Congrats on Those warrants $$$$$$$$$$$$$$$$$$
Great call buddy! What a trading week... and not over yet
called it...Just hit 1.74, 52 week high, bullish breakout time guys...lets do this.
I feel that the ambiguity of this expert panel, and not clearly delineating it as the news day (which it is likely to be), is what is keeping us in check, and may ultimately be a huge help. I would be worried if we were too much higher that we wouldn't get far on news. If we can keep people a little skeptical, or remain mostly unknown for another week, we could really explode on news with our current goat and insider ownership structure.
This may be one of the few times that the lower we are before news, the higher we'll go on news. Roll of the dice brother. Take care
Hey Bull, I think you are likely correct. Really hard to say though. With the float pretty low, and seeing a lot of consistent buys over 1.20. I really don't think it would take too much attention to send this much higher, but I also can't imagine too many people taking a large legitimate interest in this a week before news. With the rise, big question always becomes if approval is baked into the price, and luckily I feel we are far from that, if results are better than marginal. Too many variables to guess. My gut feeling though, is that we won't stay at this level too long, and that it's not a maintainable level for various reasons, good and bad.
I agree. Another bio I follow had discussed their new data at their KOL event with analysts and bankers. Would make no sense to have a KOL event without a strong agenda.
I also really like the fact that they are spun off from, and still owned in majority by Ligand. Ligand is a successful company with commercial products and even VK5211 was developed by Ligand. I feel very good about the upcoming phase 2 readout.
Agreed Titan, they announced that enrolment was completed for VK5211 on July 12 which is a 12 week trial. My guess is although they announced the enrolment on the 12th, they likely had it completed slightly earlier which puts results right around the conference in October.
Thanks BrazenBull! Glad to be here. I think I found this company at the right time as we are getting close to new data. GL to us all!
Hello Titan! Welcome to the board! Happy to see some new faces here!
We have had a very nice run the last few days. Mite need to let the rsi rest for a day or two before our next leg up. Certainly looking for some decent news. My guess is we should be fine. Any thoughts Waffles?
Man the more I read about vk2809 the more I like
Volume so far today is strong, looks like a afternoon Rally setting up.
VKTX
Strongly agree. Any things possible, but this seems like a calculated and smart approach to presenting (hopefully good) data
I agree. They have full control over when they can schedule a KOL event and it wouldn't make sense to have it a week or two before data. I think we will have data on or before October 9th.
Do U think they'd have this presentation prior to announcing the PII results? Guess anything is possible but i think it defies logic??
Followers
|
105
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1982
|
Created
|
09/18/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |